Use of GLP-1 drugs in type 2 diabetes tied to reduced risk of colorectal cancer: JAMA Medha Baranwal9 Dec 2023 11:30 AM ISTUSA: A nationwide cohort study revealed a greater reduction in the risk of colorectal cancer (CRC) with the use of glucagon-like peptide 1 (GLP-1)...
Merck to stop phase 3 trial of Keytruda plus Lynparza for lung cancer patients Ruchika Sharma8 Dec 2023 3:19 PM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced that it will stop the Phase 3 KEYLYNK-008 trial evaluating...
Bristol Myers Squibb Abecma approved for use in earlier lines of therapy for patients with relapsed or refractory Multiple Myeloma in Japan Ruchika Sharma7 Dec 2023 4:30 PM ISTTokyo: Bristol-Myers Squibb K.K. has announced that the company has received manufacturing and marketing approval of the supplemental New Drug...
USFDA accepts for priority review Bristol Myers Squibb application for Opdivo plus Cisplatin-Based Chemotherapy for urothelial carcinoma Ruchika Sharma7 Dec 2023 12:30 PM ISTPrinceton: Bristol Myers Squibb has announced that the U.S. Food and Drug Administration (FDA) has accepted the supplemental Biologics License...
Long-chain fatty acid in beef and dairy improves immune response to cancer, study finds Dr. Kamal Kant Kohli7 Dec 2023 12:00 PM ISTUSA: A recent study published in Nature has shown that trans-vaccenic acid (TVA) improves the ability of CD8+ T cells to infiltrate tumours and kill...
Studies help explain why some prostate cancers become resistant to hormone therapy Roshni Dhar7 Dec 2023 9:15 AM ISTTwo new studies led by researchers from the UCLA Jonsson Comprehensive Cancer Center give insight into how cells use energy to influence the way...
Persistent Health Challenges Faced by LGB Survivors of Adolescent and Young Adult Cancers Roshni Dhar7 Dec 2023 9:00 AM ISTStudies have indicated that minority sexual orientation and gender identity populations have higher prevalence rates of many chronic conditions...
Consumption of ultra-processed foods tied to higher risk of mouth, throat and oesophagus cancers: Study Dr. Kamal Kant Kohli7 Dec 2023 7:45 AM ISTUK: A recent study published in the European Journal of Nutrition has revealed an association between ultra-processed foods (UPF) consumption and a...
JnJ gets USFDA breakthrough therapy designation for TAR 200 for bladder cancer treatment Ruchika Sharma5 Dec 2023 11:27 AM ISTTAR-200 is a novel investigational targeted releasing system designed to provide sustained local release of gemcitabine into the bladder.
AbbVie to acquire ImmunoGen, including its flagship cancer therapy Elahere Ruchika Sharma4 Dec 2023 11:30 AM ISTNorth Chicago, Ill.: AbbVie Inc. and ImmunoGen, Inc. have announced a definitive agreement under which AbbVie will acquire ImmunoGen, and its flagship...
Oral VEGFR-TKIs use in patients with cancer linked to aneurysm and artery dissection Dr Riya Dave4 Dec 2023 2:30 AM ISTA recent national cohort study conducted in Korea has uncovered concerning evidence regarding the association between oral Vascular Endothelial Growth...
Merck application for Keytruda plus Padcev for Urothelial Cancer gets USFDA priority review Ruchika Sharma2 Dec 2023 2:30 PM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced that the U.S. Food and Drug Administration (FDA) has accepted...
